CRISPR Therapeutics AG 10-Q for FY2021 Q1
CRISPR Therapeutics AG (CRSP)
10-Q
2021-04-27
For: 2021-03-31
View Original
Added on
April 09, 2026
About this 10-Q
CRISPR Therapeutics AG filed this 10-Q on April 27, 2021, covering the quarter ended March 31, 2021 (FY2021 Q1).
Headline figures
Quarter ended March 31, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $539K
- up 243.3% from $157K a year earlier
- Net loss
- $113.16M
- compared with a net loss of $69.73M a year earlier
- Diluted EPS
- -$1.51
- compared with -$1.15 a year earlier